Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. No visible changes to study details or page layout.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe footer now shows Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check50 days agoChange DetectedThe update is a minor site version change from v3.4.0 to v3.4.1; no study data, endpoints, or locations appear to have changed.SummaryDifference0.0%

- Check64 days agoChange DetectedShow glossary feature added. Metadata updates include capitalization tweaks for QC criteria and No FEAR Act data, and the revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

- Check71 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.